Novartis to supply cholesterol drug to high-risk patients in UK

▴ Novartis
The Swiss drug maker will provide the drug to patients with Atherosclerosis.

Global pharma giant Novartis, has struck a deal with UK government to supply late-stage cholesterol drug to patients with high-risk of heart attack. The drug will be administered to patients with Atherosclerosis, a heart disease in which plaque builds up inside arteries, and can lead to heart attack, stroke or death.

The drug, which is pending approval in USA, will be provided on population basis, once it is tested in a large clinical trial and approved for use there. The drug called Inclisiran, targets protein that is involved in producing LDL, or bad cholesterol. The drug is intended to be used in addition to statins for patients who struggle to lower cholesterol with traditional therapy.

Tags : #novartis #novartisdealwithukgovernment #drug #patients #internationalmedicircle

About the Author

Ashesh Pandia

Related Stories

Loading Please wait...

Trending Now

China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
Over 200 travellers from India barred from Dubai flight over invalid Covid-19 testsSeptember 29, 2020
Netherland focuses on more stricker rule to comabt COVID-19 September 29, 2020
WHO aims to provide 120 Million rapid Coronavirus tests for poorer statesSeptember 29, 2020
UN chief on 1 Million COVID-19 deathsSeptember 29, 2020
Bahrain reports 585 Covid-19 cases, 777 recoveriesSeptember 28, 2020
Bringing hepatitis C testing and treatment to underserved communities in MadridSeptember 28, 2020
Polish doctor recovers from severe COVID-19 through rehabilitationSeptember 28, 2020
WHO supports rehabilitation of COVID-19 and other patients in UkraineSeptember 28, 2020
WHO work with migrant camps in Greece September 28, 2020
US employers being sued for COVID-19 infection spread September 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission :WHOSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020
New York to permanently switch to outdoor dining amid pandemicSeptember 26, 2020
WHO gave blessing for Coronavirus vaccine emergency use programme: ChinaSeptember 26, 2020
US surpasses 7 Million Coronavirus casesSeptember 26, 2020